FDA Revises Uncomplicated Gonorrhea Draft Guidance

Clinical Trials Advisor
A A
The FDA is making minor changes to its recommendations for sponsors developing new treatments for all types of uncomplicated gonorrhea.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00